analyst-ratings

Ignite It
3 min read • October 17, 2018

Cannabis Stocks Largely Down On Canada’s First Day Of Legal Leaf

Ignite It
3 min read • October 17, 2018

The ‘420 Investor’ Talks Canada’s Legalization, Calls Cannabis Stocks A Crowded Trade Right Now

Ignite It
2 min read • October 17, 2018

Morgan Stanley Says Canadian Auto Insurer Could Feel The Heat From Cannabis Legalization

Ignite It
2 min read • October 16, 2018

Benchmark Out Bullish On ‘Well-Positioned’ Tilray Ahead of Canada’s Cannabis Legalization

Ignite It
3 min read • October 14, 2018

4 Major Market Opportunities For The Cannabis Industry

Ignite It
3 min read • October 10, 2018

Analyst On Cannabis Stocks: You Have To Be Careful With Valuations

Ignite It
1 min read • October 10, 2018

Tigress Financial’s Feinseth On Cannabis Space Notes, There Is ‘A lot of money chasing a few names…it is a bit of a mania,’ But Admits He Doesn’t Know A Lot About The Stocks; Warns ‘gotta be careful with valuations’

Ignite It
3 min read • October 9, 2018

Cowen Dives Into The Cannabis Industry: ‘Large Market Opportunities’

Ignite It
1 min read • October 9, 2018

420 Investor Alan Brochstein, On Aurora Cannabis Listing On NYSE, Tells Benzinga News Is ‘Slight negative for Cronos and Tilray in my view as more companies list… [There are] more options now’

Ignite It
4 min read • September 27, 2018

Tim Seymour Talks Emerging Markets, Cannabis Stocks On PreMarket Prep

Ignite It
1 min read • September 27, 2018

UPDATE: Alan Brochstein Tells Benzinga He Doesn’t See Positive Readthrough for Zynerba Pharma From The DEA’s Rescheduling of Peer GW Pharma’s CBD Drug

Ignite It
1 min read • September 18, 2018

Hearing Northland Says New Age Beverage Believes The Co. Will Debut A CBD Line At The North American Convenience Show Conf.

Browse By Channels

 After-Hours Center
 Analyst Color
 Analyst Ratings
 Andy Barr
 Asia
 Asset Sales
 Be Your Own Boss
 Binary Options
 Biotech
 Bonds
 Broad U.S. Equity ETFs
 Buybacks
 california cannabis
 Cannabis
 cannabis earnings
 cannabis farms
 cannabis study
 Christopher Dillis
 CNBC
 Commodities
 Congress cannabis
 Congress hemp
 Contracts
 Crowdsourcing
 Cryptocurrency
 Currency ETFs
 Dividends
 Downgrades
 Earnings
 Earnings Beats
 Earnings Misses
 Econ #s
 Economics
 Education
 Emerging Market ETFs
 Emerging Markets
 Entertainment
 Entrepreneurship
 Equities
 ESG
 ETFs
 Eurozone
 Events
 Exclusives
 Fast Money
 FDA
 Federal Reserve
 Financial Advisors
 Financing
 Fintech
 first quarter earnings
 Forex
 Futures
 Gaming
 General
 Global
 Government
 Guidance
 Health Care
 Hedge Funds
 hemp bill
 hemp legalization
 hemp regulation
 Hot
 illegal cannabis farms
 Initiation
 Insider Trades
 Insurance
 Interview
 intoxicating hemp-derived products
 Intraday Update
 IPOs
 James Comer
 Large Cap
 Latin America
 Legal
 Long Ideas
 M&A
 Macro Economic Events
 Macro Notification
 Management
 marijuana
 Market Summary
 Market-Moving Exclusives
 Markets
 Media
 Mid Cap
 Movers
 Movers & Shakers
 New ETFs
 News
 Offerings
 Opinion
 Options
 Penny Stocks
 Personal Finance
 Politics
 Pre-Market Outlook
 Press Releases
 Previews
 Price Target
 Psychedelics
 Psychology
 Real Estate
 Regulations
 REIT
 Reiteration
 Rescheduling
 Restaurants
 Retail Sales
 Reviews
 Rumors
 SEC
 Sector ETFs
 Short Ideas
 Short Sellers
 Signals
 Small Business
 Small Cap
 Small Cap Analysis
 Social Media
 Specialty ETFs
 Sports
 Sports Betting
 Startups
 Stock Split
 Success Stories
 Taxes
 Tech
 Technicals
 THC
 Top Stories
 Topics
 Trading Ideas
 Travel
 UC Berkeley Cannabis Research Center
 unlicensed cannabis
 Upgrades
 WIIM

Join the Cannabis Revolution

Ready to access the most aggressive cannabis intelligence platform? Get started with IGNITE IT today.